4th Quarter - Report

FORBES-TATE for ABBOTT LABORATORIES

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

Issues related to the implementation of H.R. 6147 (115th Congress) - FY 2019 Appropriations; Issues regarding FY 2020 Appropriations, including H.R. 3164/S. 2522 (Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2020) and H.R. 2740 (Labor, Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020).

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 3164 (116th), H.R. 2740 (116th), S. 2522 (116th), H.R. 6147 (116th)

Taxation/Internal Revenue Code TAX

Issues related to the implementation of medical device tax reform.

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Science/Technology SCI

Issues related to laboratory developed tests.

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Trade (domestic/foreign) TRD

Issues related to global marketing restrictions.

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

Issues related to malnutrition standards; issues related to patient self-testing.

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.